• Mashup Score: 3

    Use of ACE inhibitors and angiotensin receptor blockers was not associated with an increased rate of COVID-19 infection or mortality, according to two meta-analyses reported at the virtual American Heart Association Scientific Sessions. Yujiro Yokoyama, MD, surgeon at St. Luke’s University Health Network’s Easton Hospital, Bethlehem, Pennsylvania, and colleagues conducted two

    Tweet Tweets with this article
    • Use of #ACE inhibitors or ARBs were found to not be associated with positive rates of #COVID19 or COVID-19 mortality, according to two meta-analyses presented at #AHA20 @AHAMeetings @heartnews #cardiotwitter @mystlukes @EndocrineToday @InfectDisNews https://t.co/W9T4sFLaLJ